100 related articles for article (PubMed ID: 7925877)
1. No effect of the oral neutral endopeptidase inhibitor candoxatril, on bronchomotor tone and histamine reactivity in asthma.
Angus RM; McCallum MJ; Nally JE; Thomson NC
Eur Respir J; 1994 Jun; 7(6):1084-9. PubMed ID: 7925877
[TBL] [Abstract][Full Text] [Related]
2. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
Bevan EG; Connell JM; Doyle J; Carmichael HA; Davies DL; Lorimer AR; McInnes GT
J Hypertens; 1992 Jul; 10(7):607-13. PubMed ID: 1321186
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction.
Angus RM; Millar EA; Chalmers GW; Thomson NC
Am J Respir Crit Care Med; 1995 Jun; 151(6):2003-5. PubMed ID: 7767551
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma.
Angus RM; McCallum MJ; Hulks G; Thomson NC
Am Rev Respir Dis; 1993 May; 147(5):1122-5. PubMed ID: 8387254
[TBL] [Abstract][Full Text] [Related]
5. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
Crimi N; Polosa R; Pulvirenti G; Magrì S; Santonocito G; Prosperini G; Mastruzzo C; Mistretta A
Thorax; 1995 May; 50(5):505-10. PubMed ID: 7597662
[TBL] [Abstract][Full Text] [Related]
6. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
O'Connell JE; Jardine AG; Davidson G; Connell JM
J Hypertens; 1992 Mar; 10(3):271-7. PubMed ID: 1315825
[TBL] [Abstract][Full Text] [Related]
7. Influence of elevated plasma levels of atrial natriuretic factor on bronchial reactivity in asthma.
Hulks G; Jardine AG; Connell JM; Thomson NC
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):778-82. PubMed ID: 1826192
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endopeptidase EC 3.4.24.11 by candoxatril lowered blood pressure and increased urinary but not plasma atrial natriuretic peptide in essential hypertension.
Tunny TJ; Ziesak MD; Armstrong R; Klemm SA; Stowasser M; Finn WL; Gordon RD
J Hypertens Suppl; 1993 Dec; 11(5):S222-3. PubMed ID: 8158355
[No Abstract] [Full Text] [Related]
9. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
Angus RM; Millar EA; Chalmers GW; Thomson NC
Thorax; 1996 Jan; 51(1):71-4. PubMed ID: 8658373
[TBL] [Abstract][Full Text] [Related]
10. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure.
Kentsch M; Otter W; Drummer C; Nötges A; Gerzer R; Müller-Esch G
Eur J Clin Pharmacol; 1996; 51(3-4):269-72. PubMed ID: 9010697
[TBL] [Abstract][Full Text] [Related]
11. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
13. Effect of inhaled atrial natriuretic peptide on methacholine induced bronchoconstriction in asthma.
Angus RM; McCallum MJ; Thomson NC
Clin Exp Allergy; 1994 Aug; 24(8):784-8. PubMed ID: 7982129
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
[TBL] [Abstract][Full Text] [Related]
15. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
[TBL] [Abstract][Full Text] [Related]
16. Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.
Ando S; Rahman MA; Butler GC; Senn BL; Floras JS
Hypertension; 1995 Dec; 26(6 Pt 2):1160-6. PubMed ID: 7498988
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.
Elsner D; Müntze A; Kromer EP; Riegger GA
Am J Cardiol; 1992 Aug; 70(4):494-8. PubMed ID: 1386491
[TBL] [Abstract][Full Text] [Related]
19. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid- versus nonsteroid-treated patients with atopic asthma.
Sont JK; van Krieken JH; van Klink HC; Roldaan AC; Apap CR; Willems LN; Sterk PJ
Am J Respir Cell Mol Biol; 1997 May; 16(5):549-56. PubMed ID: 9160837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
